Evidence map›Paper›PMID 24912678›Full record

ArticleMolecular and cellular biology2014

RhoB promotes γH2AX dephosphorylation and DNA double-strand break repair.

Kenza Mamouni, Agnese Cristini, Josée Guirouilh-Barbat, Sylvie Monferran, Anthony Lemarié, Jean-Charles Faye, Bernard S Lopez, Gilles Favre, Olivier Sordet

Open access · bronzeAbstract read
In one paragraph

Article in Molecular and cellular biology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
2.7field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 37 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Review
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 6 institutions in 1 country.

Kenza MamouniCancer Research Center of Toulouse, INSERM UMR1037, Institut Claudius Regaud, Toulouse, France Université de Toulouse, Toulouse, France.
Agnese CristiniCancer Research Center of Toulouse, INSERM UMR1037, Institut Claudius Regaud, Toulouse, France Université de Toulouse, Toulouse, France.
Josée Guirouilh-BarbatCNRS UMR8200, Institut de Cancérologie Gustave Roussy, Université Paris XI, Villejuif, France.
Sylvie MonferranCancer Research Center of Toulouse, INSERM UMR1037, Institut Claudius Regaud, Toulouse, France Université de Toulouse, Toulouse, France.
Anthony LemariéCancer Research Center of Toulouse, INSERM UMR1037, Institut Claudius Regaud, Toulouse, France Université de Toulouse, Toulouse, France.
Jean-Charles FayeCancer Research Center of Toulouse, INSERM UMR1037, Institut Claudius Regaud, Toulouse, France.
Bernard S LopezCNRS UMR8200, Institut de Cancérologie Gustave Roussy, Université Paris XI, Villejuif, France.
Gilles FavreCancer Research Center of Toulouse, INSERM UMR1037, Institut Claudius Regaud, Toulouse, France Université de Toulouse, Toulouse, France favre.gilles@claudiusregaud.fr olivier.sordet@inserm.fr.
Olivier SordetCancer Research Center of Toulouse, INSERM UMR1037, Institut Claudius Regaud, Toulouse, France favre.gilles@claudiusregaud.fr olivier.sordet@inserm.fr.
Institut Claudius Regaud · FRInserm · FRCentre de Recherche en Cancérologie de Toulouse · FRCentre National de la Recherche Scientifique · FRInstitut Gustave Roussy · FRUniversité de Toulouse · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Unlike other Rho GTPases, RhoB is rapidly induced by DNA damage, and its expression level decreases during cancer progression. Because inefficient repair of DNA double-strand breaks (DSBs) can lead to cancer, we investigated whether camptothecin, an anticancer drug that produces DSBs, induces RhoB expression and examined its role in the camptothecin-induced DNA damage response. We show that in camptothecin-treated cells, DSBs induce RhoB expression by a mechanism that depends notably on Chk2 and its substrate HuR, which binds to RhoB mRNA and protects it against degradation. RhoB-deficient cells fail to dephosphorylate γH2AX following camptothecin removal and show reduced efficiency of DSB repair by homologous recombination. These cells also show decreased activity of protein phosphatase 2A (PP2A), a phosphatase for γH2AX and other DNA damage and repair proteins. Thus, we propose that DSBs activate a Chk2-HuR-RhoB pathway that promotes PP2A-mediated dephosphorylation of γH2AX and DSB repair. Finally, we show that RhoB-deficient cells accumulate endogenous γH2AX and chromosomal abnormalities, suggesting that RhoB loss increases DSB-mediated genomic instability and tumor progression.

Indexed as

DNA Breaks, Double-StrandedAnimalsAntineoplastic Agents, PhytogenicCamptothecinCell Line, TumorCheckpoint Kinase 2Chromosome AberrationsDNA RepairELAV ProteinsGenomic InstabilityHCT116 CellsHistonesHumansMiceMice, KnockoutPhosphorylationAntineoplastic Agents, PhytogenicCamptothecinCheckpoint Kinase 2Chek2 protein, mouseELAV Proteinsgamma-H2AX protein, mouseHistonesProtein Phosphatase 2rhoB GTP-Binding ProteinRNA-Binding ProteinsRNA, Small InterferingTopoisomerase I Inhibitors

Identifiers

PMID24912678
PMCPMC4135599
OpenAlexW2159989508

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.